Zuo‐Feng Zhang
Impact in
- Cancer Research top 0.2%
- Oncology top 0.5%
- Cancer-related Molecular Pathways
Papers in
-
- Cancer, Lipids, and Metabolism 28
- Oncology 128
- Cancer-related Molecular Pathways 32
- Cancer Risks and Factors 27
- Co-authors
- Guozhong CaoEvan UchakerLi LiRui FuStephanie L. CandelariaGuido DalbagniMia HashibeWilliam R. Fair
- Journals
- International Journal of Cancer (31 papers)Cancer Causes & Control (14 papers)Cancer Epidemiology Biomarkers & Prevention (14 papers)The Journal of Urology (11 papers)PLoS ONE (11 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Zuo‐Feng Zhang
652 papers receiving 28.9k citations
Hit Papers
Peers
Comparison fields: 5 of 222
- Cancer Research 3.4k
- Oncology 4.6k
- Otorhinolaryngology 729
- Urology 923
- Molecular Biology 9.2k
Countries citing papers authored by Zuo‐Feng Zhang
This map shows the geographic impact of Zuo‐Feng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuo‐Feng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuo‐Feng Zhang more than expected).
Fields of papers citing papers by Zuo‐Feng Zhang
This network shows the impact of papers produced by Zuo‐Feng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuo‐Feng Zhang. The network helps show where Zuo‐Feng Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuo‐Feng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 65 | |
| 12 | 2020 | 15 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 19 | |
| 15 | 2017 | 4 | |
| 16 | 2016 | 42 | |
| 17 | 2015 | 8 | |
| 18 | 2012 | 45 | |
| 19 | 2011 | 65 | |
| 20 | 2010 | 37 |
About Zuo‐Feng Zhang
Zuo‐Feng Zhang is a scholar working on Cancer Research, Oncology, Otorhinolaryngology, Pathology and Forensic Medicine and Molecular Biology, having authored 680 papers that have together received 29.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (36 papers), Cancer-related Molecular Pathways (32 papers), Cancer, Lipids, and Metabolism (28 papers), Cancer Risks and Factors (27 papers), Metabolism, Diabetes, and Cancer (23 papers), Epigenetics and DNA Methylation (23 papers), Liver Disease Diagnosis and Treatment (21 papers) and Supercapacitor Materials and Fabrication (20 papers). The work is most often cited by research in Cancer Research (3.4k citations), Oncology (4.6k citations), Otorhinolaryngology (729 citations), Urology (923 citations) and Molecular Biology (9.2k citations). Zuo‐Feng Zhang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Guozhong Cao, Evan Uchaker, Li Li, Rui Fu, Stephanie L. Candelaria, Guido Dalbagni, Mia Hashibe, William R. Fair, Carlos Cordon‐Cardo and Adrian R. Krainer. Their work appears in journals such as International Journal of Cancer, Cancer Causes & Control, Cancer Epidemiology Biomarkers & Prevention, The Journal of Urology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.